Naturalendo Tech Broadens Alliance with CK Ingredients
06 Sep 2016 --- Korean biotechnology company Naturalendo Tech, a recognized leader in science-based nutritional ingredient solutions, has recently expanded its relationship with Toronto, Canada-based raw material supplier CK Ingredients (CK).
Effective August 5th, CK was appointed Naturalendo’s exclusive US distributor for EstroG-100, its patented evidence-based natural ingredient for relief of menopausal symptoms.
“CK Ingredients has done an excellent job representing Naturalendo Tech in Canada over the past five years, helping us to secure regulatory approval and driving business with some of the largest and most reputable dietary supplement brands in the Canadian market,” said Hyunwoo Chang, president and CEO of Naturalendo Tech. “In light of this success, we are pleased to appoint CK as our new exclusive partner in the world’s largest dietary supplement market, the U.S.”
Michael Chernyak, President & CEO of CK Ingredients added, “We’re truly honored that Naturalendo Tech is entrusting us with its US business. EstroG-100 is one of the finest nutraceutical raw materials that I’ve come across in my twenty years in the natural products industry, and CK Ingredients looks forward to supporting US dietary supplement brands in the development of safe and effective natural solutions for menopause support.”
EstroG-100 is comprised of three evidence-based botanicals. Backed by three gold-standard human clinical studies and extensive safety data, it’s among the most successful menopause relief ingredients globally, contributing hundreds of millions of dollars in revenue annually, at the consumer level. EstroG-100 maintains a Health Canada license (including an excellent approved claim) as well as FDA NDI approval in the US.
CK Ingredients and Naturalendo together will present EstroG-100 at the upcoming Supply Side West trade show in Las Vegas, on October 6th and 7th.
To contact our editorial team please email us at editorial@cnsmedia.com
Subscribe now to receive the latest news directly into your inbox.